Literature DB >> 16514312

Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings.

Louise C Ivers1, Joia S Mukherjee.   

Abstract

Lactic acidosis is a rare but potentially life-threatening complication of antiretroviral therapy (ART) and is commonly considered in the differential diagnosis of patients on ART. In the developing world, definitive diagnosis by laboratory measurement of lactate may be impossible. Point-of-care devices are available that provide simple, accurate measurements of lactic acid levels at relatively low cost. Their use in an HIV treatment programme in rural Haiti has greatly assisted clinical decision-making in patients with symptoms suggestive of lactic acidosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514312     DOI: 10.1097/01.aids.0000216382.37679.b2

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.

Authors:  Marilyn J Crain; Paige L Williams; Ray Griner; Katherine Tassiopoulos; Jennifer S Read; Lynne M Mofenson; Kenneth C Rich
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda.

Authors:  M Waiswa; B B Byarugaba; P Ocama; H Mayanja-Kizza; E Seremba; S Ganguli; M Crowther; R Colebunders
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana.

Authors:  Sikhulile Moyo; Hermann Bussmann; Phibeon Mangwendeza; Priti Dusara; Tendani Gaolathe; Madisa Mine; Rosemary Musonda; Erik van Widenfelt; Vladimir Novitsky; Joseph Makhema; Richard G Marlink; Max Essex; C William Wester
Journal:  J Antivir Antiretrovir       Date:  2011-09-20

4.  Point-of-care lactate and creatinine analysis for sick obstetric patients at Queen Elizabeth Central Hospital in Blantyre, Malawi: A feasibility study.

Authors:  S A Glasmacher; P Bonongwe; W Stones
Journal:  Malawi Med J       Date:  2016-03       Impact factor: 0.875

5.  A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy.

Authors:  Lynn T Matthews; Janet Giddy; Musie Ghebremichael; Jane Hampton; Anthony J Guarino; Aba Ewusi; Emma Carver; Karen Axten; Meghan C Geary; Rajesh T Gandhi; David R Bangsberg
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

6.  Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities.

Authors:  Newton Chagoma; Jane Mallewa; Symon Kaunda; Yasin Njalale; Elizabeth Kampira; Mavuto Mukaka; Robert S Heyderman; Joep J van Oosterhout
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-08-07       Impact factor: 2.184

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.